Cargando…
Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel
BACKGROUND: Glioblastomas (GBM) are rapidly progressive, nearly uniformly fatal brain tumors. Proteomic analysis represents an opportunity for noninvasive GBM classification and biological understanding of treatment response. PURPOSE: We analyzed differential proteomic expression pre vs. post comple...
Autores principales: | Krauze, Andra Valentina, Sierk, Michael, Nguyen, Trinh, Chen, Qingrong, Yan, Chunhua, Hu, Ying, Jiang, William, Tasci, Erdal, Zgela, Theresa Cooley, Sproull, Mary, Mackey, Megan, Shankavaram, Uma, Meerzaman, Daoud, Camphausen, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448824/ https://www.ncbi.nlm.nih.gov/pubmed/37637066 http://dx.doi.org/10.3389/fonc.2023.1127645 |
Ejemplares similares
-
RadWise: A Rank-Based Hybrid Feature Weighting and Selection Method for Proteomic Categorization of Chemoirradiation in Patients with Glioblastoma
por: Tasci, Erdal, et al.
Publicado: (2023) -
Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation
por: Krauze, Andra V., et al.
Publicado: (2023) -
Chemoirradiation for Glioblastoma Multiforme: The National Cancer Institute Experience
por: Ho, Jennifer, et al.
Publicado: (2013) -
SDPS-29 SERUM-DERIVED CD47 AS A MARKER OF TUMOR BURDENAND OUTCOME IN GBM PATIENTS – CORRELATIVE ANALYSISOF TUMOR LOCATION, RADIATION THERAPY VOLUMES,AND SURVIVAL
por: Jagasia, Sarisha, et al.
Publicado: (2023) -
The Next Frontier in Health Disparities—A Closer Look at Exploring Sex Differences in Glioma Data and Omics Analysis, from Bench to Bedside and Back
por: Diaz Rosario, Maria, et al.
Publicado: (2022)